- Lilly scores early positive data for new JAK drug<figure><div><img src="https://imgproxy.divecdn.com/BektaG64-yby8Y5l-Eb4j51Y6ClyucnWH1-PThZhx4E/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDE0NDc0NzEzLmpwZ…BioPharma Dive · 1mo ago↗ source
- J&J multiple myeloma drug gains edge in earlier stage disease<figure><div><img src="https://imgproxy.divecdn.com/cm_W-FdbiM9BbB0zoOGzQIxUTIYDjzY9Hg-zhECEdaE/g:nowe:208:253/c:1738:982/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS85MzMxNjUxLWZh…BioPharma Dive · 1mo ago↗ source
- STAT+: Lilly’s Ajax acquisition may have been worth itA syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The ReadoutSTAT · 1mo ago